Sign In
Buy WW
$18.33
-0.0800 (-0.435%)
At Close: Jun 23, 2026
Weight Watchers Announces Board Committee Appointments
07:30am, Thursday, 09'th Apr 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced th
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
07:30am, Tuesday, 07'th Apr 2026
New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to
Weight Watchers Announces Leadership Transition and Board Updates
02:09pm, Friday, 03'rd Apr 2026
Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW
Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight W
WW International, Inc. (WGHTQ) Q4 2025 Earnings Call Transcript
11:52am, Monday, 16'th Mar 2026
WW International, Inc. (WGHTQ) Q4 2025 Earnings Call Transcript
WW International beats fourth quarter estimates on clinical subscription growth
10:55am, Monday, 16'th Mar 2026
WW International (NASDAQ:WW), the global weight management company formerly known as Weight Watchers, released its fourth quarter and full-year 2025 financial results, showing stronger-than-expected e
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
07:00am, Monday, 16'th Mar 2026
2025 Total Revenue and Adjusted EBITDA 1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% yea
WW International, Inc. (NASDAQ:WW) Short Interest Up 28.9% in February
01:03am, Tuesday, 03'rd Mar 2026
WW International, Inc. (NASDAQ: WW - Get Free Report) was the target of a large growth in short interest in February. As of February 13th, there was short interest totaling 1,593,503 shares, a growth
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
04:01pm, Friday, 27'th Feb 2026
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended De
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
09:00am, Tuesday, 10'th Feb 2026
The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life The new p
A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone A NovoCare® Recogniz
WW International (NASDAQ:WW) Share Price Passes Above 200-Day Moving Average – Here’s What Happened
02:56am, Tuesday, 30'th Dec 2025
WW International, Inc. (NASDAQ: WW - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $27.60 and traded as high as $29.40.
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
09:05am, Tuesday, 16'th Dec 2025
A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss g
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
08:55am, Tuesday, 16'th Dec 2025
A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and
WW International: First Normal Quarter Shows Signs Of Stability
01:03pm, Tuesday, 18'th Nov 2025
WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cau
